Lateral flow test owners are concerned
As the world continues to experience geo-political impacts and variable COVID-19 spikes across international borders, attention inevitably turns to how these factors could potentially impact manufacturing certainty and delivery of critical lateral flow rapid tests.
These resulting pressures illustrate the need for a robust and agile manufacturing and supply plan that can respond to such challenges. Without a ‘Plan B’, such global events can reduce the sense of security and confidence in a test providers ability to supply and meet the business’ goals or customers’ demand.
With the increase in domestic demand for COVID-19 testing across many global territories leading to supply chain disruption, rapid test owners are understandably becoming concerned that their testing requirements for non-Covid-19 related products could be facing challenges.
This comes with no surprise that there is a need and drive to secure additional partners to secure manufacturing capacity and certainty of delivery.
What’s the solution?
At Abingdon Health, we have the lateral flow test knowledge; the supply chain relationships and the capacity to provide the reassurance and peace of mind that your products will be delivered to the right place, at the right time, at the right quantity and at the right price. We provide that sought after certainty, through a consistent ‘right first time’ approach.
Our customers priorities, are our priorities. All day, every day
Providing certainty on quality
At Abingdon Health we know the importance of developing and manufacturing high quality, reliable rapid tests for all our customers, no matter their specific market.
We operate under ISO 13485 and ISO 9001:2016, both of which are managed by our in-house QA/RA teams. We welcome customer audits and always look forward to sharing best practise with our customers and partners.
Our manufacturing facilities operate in accordance with GMP 21CFR820, US Food and Drug Administration (FDA), for the design, development, and manufacture of lateral flow devices, and device readers for in vitro diagnostic medical use and is a registered establishment.
Providing certainty through capacity
We have the right equipment and the right people
The Abingdon Health team are lateral flow experts. With the deployment of the latest state-of-the-art automation in assembly and primary card production, combined with many years of experience, we provide flexible capacity to produce millions of tests per week.
This flexible capacity can be placed at the disposal of our customers and enables:
- Scalable solutions to meet fluctuating forecast demands
- Rapid deployment in response to spikes such as seasonal flu demand
- Stable pricing for long-term business planning
- Guaranteed product quality at point of delivery
- Supply chain management